{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:44:12Z","timestamp":1707525852809},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,26]]},"DOI":"10.7759\/cureus.53011","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T03:27:38Z","timestamp":1706326058000},"source":"Crossref","is-referenced-by-count":0,"title":["Cefepime-Induced Generalized Fixed Drug Eruption With Morbilliform Rash"],"prefix":"10.7759","author":[{"given":"Grayson P","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley M","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A","family":"Coop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittanie I","family":"Neaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32832cda4c","article-title":"Fixed drug eruption: pathogenesis and diagnostic tests","volume":"9","author":"Shiohara T","year":"2009","unstructured":"Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009, 9:316-21. 10.1097\/ACI.0b013e32832cda4c","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)64410-0","article-title":"Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption","volume":"161","author":"Mizukawa Y","year":"2002","unstructured":"Mizukawa Y, Yamazaki Y, Teraki Y, et al.. Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption. Am J Pathol. 2002, 161:1337-47. 10.1016\/s0002-9440(10)64410-0","journal-title":"Am J Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08516.x","article-title":"In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption","volume":"158","author":"Mizukawa Y","year":"2008","unstructured":"Mizukawa Y, Yamazaki Y, Shiohara T. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol. 2008, 158:1230-8. 10.1111\/j.1365-2133.2008.08516.x","journal-title":"Br J Dermatol"},{"key":"ref4","article-title":"Rates of cutaneous reactions to drugs","volume":"137","author":"Bigby M","year":"2001","unstructured":"Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001, 137:765-70.","journal-title":"Arch Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200001050-00003","article-title":"Fixed drug eruptions. Incidence, recognition, and avoidance","volume":"1","author":"Lee AY","year":"2000","unstructured":"Lee AY. Fixed drug eruptions. Incidence, recognition, and avoidance. Am J Clin Dermatol. 2000, 1:277-85. 10.2165\/00128071-200001050-00003","journal-title":"Am J Clin Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00451.x","article-title":"Drugs causing fixed eruptions: a study of 450 cases","volume":"37","author":"Mahboob A","year":"1998","unstructured":"Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol. 1998, 37:833-8. 10.1046\/j.1365-4362.1998.00451.x","journal-title":"Int J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2010.0980","article-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France","volume":"20","author":"Brahimi N","year":"2010","unstructured":"Brahimi N, Routier E, Raison-Peyron N, et al.. A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol. 2010, 20:461-4. 10.1684\/ejd.2010.0980","journal-title":"Eur J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.136","article-title":"An adolescent male presenting with nonpigmenting fixed drug eruption to ceftriaxone","volume":"137","author":"Byrne A","year":"2016","unstructured":"Byrne A, Ben-Shoshan M. An adolescent male presenting with nonpigmenting fixed drug eruption to ceftriaxone. J Allergy Clin Immunol. 2016, 137:AB41. 10.1016\/j.jaci.2015.12.136","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2018.10.006","article-title":"Cefotaxime induced generalized bullous fixed drug eruption - a case report","volume":"5","author":"Manikandan R","year":"2018","unstructured":"Manikandan R, Porselvi A, Keerthana GC, Vaishnavi K, Girija S, Narasimhan M, Vijayakumar TM. Cefotaxime induced generalized bullous fixed drug eruption - a case report. Toxicol Rep. 2018, 5:1011-3. 10.1016\/j.toxrep.2018.10.006","journal-title":"Toxicol Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.30738.x","article-title":"T cell receptor (TCR) repertoire and function of human epidermal T cells: restricted TCR V alpha-V beta genes are utilized by T cells residing in the lesional epidermis in fixed drug eruption","volume":"104","author":"Komatsu T","year":"1996","unstructured":"Komatsu T, Moriya N, Shiohara T. T cell receptor (TCR) repertoire and function of human epidermal T cells: restricted TCR V alpha-V beta genes are utilized by T cells residing in the lesional epidermis in fixed drug eruption. Clin Exp Immunol. 1996, 104:343-50. 10.1046\/j.1365-2249.1996.30738.x","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips EJ","year":"2019","unstructured":"Phillips EJ, Bigliardi P, Bircher AJ, et al.. Controversies in drug allergy: testing for delayed reactions. J Allergy Clin Immunol. 2019, 143:66-73. 10.1016\/j.jaci.2018.10.030","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2009.04.010","article-title":"Skin testing in delayed reactions to drugs","volume":"29","author":"Barbaud A","year":"2009","unstructured":"Barbaud A. Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am. 2009, 29:517-35. 10.1016\/j.iac.2009.04.010","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/214817-cefepime-induced-generalized-fixed-drug-eruption-with-morbilliform-rash","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:15:40Z","timestamp":1707509740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/214817-cefepime-induced-generalized-fixed-drug-eruption-with-morbilliform-rash"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.53011","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,26]]}}}